AVA
Atlas Venture Advisors Portfolio holdings
AUM
$424M
This Quarter Return
-6.5%
1 Year Return
+0.16%
3 Year Return
+108.89%
5 Year Return
+64.67%
10 Year Return
–
AUM
$720M
AUM Growth
+$720M
(-15%)
Cap. Flow
-$12.8M
Cap. Flow
% of AUM
-1.78%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
–
Closed
1
Top Buys
| 1 |
Integral Ad Science
IAS
|
$22 |
Top Sells
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
$12.8M |
Sector Composition
| 1 | Communication Services | 73.56% |
| 2 | Consumer Discretionary | 25.02% |
| 3 | Healthcare | 1.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Integral Ad Science
IAS
$1.49B
| $505M | 70.13% | 22,722,771 +1 | +0% | +$22 |
|
2
DraftKings
DKNG
$23.8B
| $180M | 25.02% | 6,555,608 | – | – |
|
3
Roku
ROKU
$14.2B
| $13.2M | 1.83% | 57,707 | – | – |
|
4
Snap
SNAP
$12.1B
| $11.5M | 1.6% | 245,559 | – | – |
|
5
Viridian Therapeutics
VRDN
$1.5B
| $4.14M | 0.58% | 209,505 | – | – |
|
6
Larimar Therapeutics
LRMR
$310M
| $3.15M | 0.44% | 292,184 | – | – |
|
|
FSTX
7
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $2.89M | 0.4% | 574,996 | – | – |
|
|
BCYC
8
Bicycle Therapeutics
BCYC
$511M
| – | – | -307,696 | Closed | -$12.8M |
|